Regulation And Legal
Saptak Chem Confirms No Preferential Issue Fund Deviation
Saptak Chem discloses no deviation in utilization of ₹4.20 crore raised through preferential convertible warrant issuance.
Company received ₹1.05 crore as 25% consideration from allottees for 40 lakh
